VFMCRP
- Business Wire
VFMCRP announces positive results of phase-III clinical trial of Velphoro® in China
Met primary efficacy endpoint of non-inferiority versus sevelamer carbonate Velphoro® effective in lowering and maintaining serum phosphorus level Safety profile…
Read More » - Business Wire
VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
Companies have successfully submitted the EU regulatory application for marketing authorization for difelikefalin If approved, difelikefalin injection will be the…
Read More » - Health
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
St. Gallen, Switzerland & Mountain View, Calif., United States: As in ANCA vasculitis, avacopan demonstrated statistically significant improvement in renal…
Read More » - Business
VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement
Bad Homburg, Germany & St. Gallen, Switzerland: Veltassa® is a well-tolerated1 and effective2 oral calcium potassium binder for the treatment of hyperkalemia supported…
Read More » - United States
VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
St. Gallen, Switzerland & Mountain View, Calif., United States: Companies have completed the EU regulatory application for marketing approval of…
Read More »